239 related articles for article (PubMed ID: 21521770)
21. The relative importance of CYP26A1 in hepatic clearance of all-trans retinoic acid.
Thatcher JE; Zelter A; Isoherranen N
Biochem Pharmacol; 2010 Sep; 80(6):903-12. PubMed ID: 20513361
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity.
Van Heusden J; Van Ginckel R; Bruwiere H; Moelans P; Janssen B; Floren W; van der Leede BJ; van Dun J; Sanz G; Venet M; Dillen L; Van Hove C; Willemsens G; Janicot M; Wouters W
Br J Cancer; 2002 Feb; 86(4):605-11. PubMed ID: 11870544
[TBL] [Abstract][Full Text] [Related]
23. Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death.
Osanai M; Petkovich M
Mol Pharmacol; 2005 May; 67(5):1808-17. PubMed ID: 15703382
[TBL] [Abstract][Full Text] [Related]
24. Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding.
Gomaa MS; Yee SW; Milbourne CE; Barbera MC; Simons C; Brancale A
J Enzyme Inhib Med Chem; 2006 Aug; 21(4):361-9. PubMed ID: 17059167
[TBL] [Abstract][Full Text] [Related]
25. Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers.
Idres N; Marill J; Flexor MA; Chabot GG
J Biol Chem; 2002 Aug; 277(35):31491-8. PubMed ID: 12070176
[TBL] [Abstract][Full Text] [Related]
26. Small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26): synthesis and biological evaluation of imidazole methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates.
Gomaa MS; Bridgens CE; Aboraia AS; Veal GJ; Redfern CP; Brancale A; Armstrong JL; Simons C
J Med Chem; 2011 Apr; 54(8):2778-91. PubMed ID: 21428449
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.
Foti RS; Diaz P; Douguet D
J Enzyme Inhib Med Chem; 2016; 31(sup2):148-161. PubMed ID: 27424662
[TBL] [Abstract][Full Text] [Related]
28. Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells.
Gomaa MS; Armstrong JL; Bobillon B; Veal GJ; Brancale A; Redfern CP; Simons C
Bioorg Med Chem; 2008 Sep; 16(17):8301-13. PubMed ID: 18722776
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles.
Pautus S; Yee SW; Jayne M; Coogan MP; Simons C
Bioorg Med Chem; 2006 Jun; 14(11):3643-53. PubMed ID: 16458519
[TBL] [Abstract][Full Text] [Related]
30. Effect of NADPH-cytochrome P450 reductase on all-trans-retinoic acid efficacy and cytochrome P450 26A1 expression in human myeloid leukaemia HL-60 cells.
Hu L; Lv JF; Zhuo W; Zhang CM; Zhou HH; Fan L
J Pharm Pharmacol; 2016 Sep; 68(9):1193-202. PubMed ID: 27366899
[TBL] [Abstract][Full Text] [Related]
31. Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells.
Armstrong JL; Ruiz M; Boddy AV; Redfern CP; Pearson AD; Veal GJ
Br J Cancer; 2005 Feb; 92(4):696-704. PubMed ID: 15714209
[TBL] [Abstract][Full Text] [Related]
32. Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo.
Zolfaghari R; Cifelli CJ; Lieu SO; Chen Q; Li NQ; Ross AC
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1029-36. PubMed ID: 17185629
[TBL] [Abstract][Full Text] [Related]
33. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
Foti RS; Isoherranen N; Zelter A; Dickmann LJ; Buttrick BR; Diaz P; Douguet D
J Pharmacol Exp Ther; 2016 May; 357(2):281-92. PubMed ID: 26937021
[TBL] [Abstract][Full Text] [Related]
34. Improved Homology Model of the Human all-trans Retinoic Acid Metabolizing Enzyme CYP26A1.
Awadalla MK; Alshammari TM; Eriksson LA; Saenz-Méndez P
Molecules; 2016 Mar; 21(3):351. PubMed ID: 26999080
[TBL] [Abstract][Full Text] [Related]
35. The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system.
Lee SJ; Perera L; Coulter SJ; Mohrenweiser HW; Jetten A; Goldstein JA
Pharmacogenet Genomics; 2007 Mar; 17(3):169-80. PubMed ID: 17460545
[TBL] [Abstract][Full Text] [Related]
36. Multiple cytochrome P-450 genes are concomitantly regulated by vitamin A under steady-state conditions and by retinoic acid during hepatic first-pass metabolism.
Ross AC; Cifelli CJ; Zolfaghari R; Li NQ
Physiol Genomics; 2011 Jan; 43(1):57-67. PubMed ID: 21045116
[TBL] [Abstract][Full Text] [Related]
37. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures.
Abu-Abed S; Dollé P; Metzger D; Beckett B; Chambon P; Petkovich M
Genes Dev; 2001 Jan; 15(2):226-40. PubMed ID: 11157778
[TBL] [Abstract][Full Text] [Related]
38. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells.
Sonneveld E; van den Brink CE; van der Leede BM; Schulkes RK; Petkovich M; van der Burg B; van der Saag PT
Cell Growth Differ; 1998 Aug; 9(8):629-37. PubMed ID: 9716180
[TBL] [Abstract][Full Text] [Related]
39. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte nuclear factor 4α (HNF4α) in coordination with retinoic acid receptors increases all-trans-retinoic acid-dependent CYP26A1 gene expression in HepG2 human hepatocytes.
Zolfaghari R; Ross AC
J Cell Biochem; 2014 Oct; 115(10):1740-51. PubMed ID: 24819304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]